Maharashtra has become the first state in India to begin granting registration under the Maharashtra Medical Council to homoeopathic doctors who have completed a one-year Certificate Course in Modern Pharmacology. The move has triggered an indefinite agitation by modern medicine practitioners who argue that the decision does far more than expand limited prescribing rights. At its core, they say, it places bridge-course-qualified homoeopaths on the same statutory register as MBBS doctors, blurring regulatory boundaries that have long separated different systems of medicine.
The first conditional registration was issued in early August. Within hours, outpatient departments in many government hospitals emptied as resident doctors and members of the Indian Medical Association withdrew non-emergency services. The conflict has revived a legal and professional dispute that has simmered for more than a decade.
What the Certificate Course Actually Is
The Certificate Course in Modern Pharmacology, commonly known as CCMP, was introduced through a 2014 state government resolution. Conducted under the Maharashtra University of Health Sciences, it is a one-year programme, often delivered on weekends, designed for registered Bachelor of Homoeopathic Medicine and Surgery graduates. The stated purpose was to equip these practitioners with knowledge of modern drugs so they could provide limited allopathic treatment, particularly in rural and underserved areas where shortages of MBBS doctors persist.
Approximately 9,000 to 10,000 homoeopathic doctors are estimated to have completed the course over the years. Until recently, completion did not automatically confer registration with the Maharashtra Medical Council. That changed when the state directed the council to begin issuing registrations. The first certificate was granted under a conditional framework that allows practice of modern medicine only to the extent of the training received and within limits set by the government. Homoeopaths must also remain registered with their own state council.
Supporters of the policy argue that the additional year of study, layered on top of the standard BHMS curriculum and internship, creates a practitioner with meaningful exposure to modern pharmacology. They present the registration as recognition of long-pending rights and a practical step toward strengthening primary healthcare delivery.
Why Modern Medicine Doctors Object
Modern medicine associations reject this framing. Their central objection is not merely the existence of a short pharmacology course. It is the decision to place these practitioners on the Maharashtra Medical Council register itself. That register has historically been reserved for those who have completed the full MBBS pathway and subsequent requirements under the national regulatory framework for modern medicine.
Doctors argue that dual registration creates public confusion about qualifications. A patient seeing a name on the Medical Council register may reasonably assume the practitioner has undergone the same rigorous training as an MBBS graduate. They contend that a one-year certificate course, however well-intentioned, cannot be treated as equivalent to the comprehensive education in anatomy, physiology, pathology, clinical medicine, surgery and emergency care that defines modern medical training.
The term “mixopathy” is frequently used in the protests, yet many doctors insist the issue runs deeper. Limited prescribing rights under a separate regulatory arrangement might have been debated on practical grounds. Entry onto the same statutory register, they say, crosses a fundamental line. It alters the legal and professional status of two distinct systems and, in their view, dilutes the standards that patients have a right to expect from modern medicine practitioners.
The Indian Medical Association has also pointed out that the CCMP has never received approval from the National Medical Commission or the National Commission for Homoeopathy as a pathway to full modern medicine practice. The association has demanded that the course be scrapped and has warned of a wider agitation if the policy is not withdrawn. The matter has been pending before the Bombay High Court since challenges were first filed around 2014.
A Recurring Conflict, Now Escalated
This is not the first time the issue has flared. In 2025 the state temporarily suspended the registration process after similar protests and formed a committee to examine concerns. Homoeopathic practitioners responded with their own demonstrations, arguing that successive governments had repeatedly promised implementation only to retreat under pressure. The latest government resolution restarted the process, leading to the first registrations and the current indefinite strike by resident doctors and private practitioners.
The agitation has disrupted routine services in government medical colleges and hospitals across the state. Resident doctors have limited themselves to emergency care while demanding written assurances from the government. The Bombay High Court has intervened, directing doctors to call off the strike in the interest of patient safety, underscoring the immediate human cost of the standoff.
Deeper Questions of Regulation and Trust
Beneath the immediate confrontation lie larger questions about how India regulates its multiple systems of medicine. Homoeopathy, Ayurveda and modern medicine each operate under separate councils and educational standards. Bridge courses and limited cross-practice arrangements have been attempted in various forms, often justified by rural healthcare gaps. Yet each attempt raises the same unresolved tension: how far can one system’s practitioners enter the regulatory domain of another without compromising the integrity of both?
Patient safety remains the most frequently cited concern on the modern medicine side. Critics argue that incomplete training in diagnosis, differential diagnosis and management of complex or emergency conditions can lead to delayed or inappropriate care. Homoeopathic associations counter that the course is narrowly focused and that practitioners remain accountable within defined limits. The absence of a clear, nationally uniform framework leaves both sides operating in a zone of legal and professional uncertainty.
Public trust is also at stake. When regulatory boundaries become ambiguous, patients may find it harder to understand what kind of training and accountability stands behind a particular registration. Clarity, doctors argue, is itself a form of safety.
What Happens Next
The immediate future depends on whether the state pauses further registrations, offers a revised framework with stricter limitations, or allows the court process to reach a definitive conclusion. Homoeopathic practitioners who have invested years in the CCMP see the current moment as long-overdue recognition. Modern medicine organisations view it as a dangerous precedent that must be reversed.
The label “mixopathy” captures one dimension of the dispute, but it does not fully explain the intensity of the reaction. The deeper conflict is about who belongs on the statutory register that certifies modern medical practice, what that registration is understood to guarantee, and whether short bridge courses can legitimately alter that understanding. Until those questions receive clearer regulatory answers, the cycle of notification, protest and temporary suspension is likely to continue. In Maharashtra, that cycle has once again moved from administrative files into hospital corridors and courtrooms, with patients caught in between.
Read more – naejebmedia.com